At a glance
The February 27, 2023, Laboratory Outreach Communication System (LOCS) call included updates on the SARS-CoV-2 variants, H5 influenza situation, and the FDA's Resiliency Program.
Agenda
Archived LOCS Materials Access
Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems
SARS-CoV-2 Variants Update: Natalie Thornburg, CDC Division of Viral Diseases
H5 Situation Update: John Barnes, CDC Influenza Division
FDA's Resiliency Program: Tammy Beckham, US Food and Drug Administration
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.